Prescient Therapeutics Opens SPP to Raise $7m Today
Filed with ASX · · 12 pages · English
Summary by 6ix AI
Eligible shareholders can acquire new shares at a discounted price without incurring brokerage fees. The funds will also support general working capital and business development activities. A live shareholder briefing is scheduled to discuss the SPP and its intended use of funds.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Prescient Therapeutics Limited on 6ix
In the deck
Earlier from Prescient Therapeutics
- Share Purchase Plan Cleansing Notice
- Proposed issue of securities - PTX
- Prescient Therapeutics Launches Share Purchase Plan for $7m
- Appendix 4E and 2026 Annual Report
- Appendix 4G and Corporate Governance Statement
Later from Prescient Therapeutics
- Prescient Share Purchase Plan Investor Presentation
- PTX-100 CTCL Phase 2a study reaches review milestone
- Prescient Therapeutics - Extension of Share Purchase Plan
- Update - Proposed issue of securities - PTX
- Notice of Annual General Meeting/Proxy Form
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics